Ribonucleic Acid (RNA) Sequencing Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the ribonucleic acid (rna) sequencing market grown in recent years?
The market size for ribonucleic acid (RNA) sequencing has experienced rapid growth in the recent past. The market is forecasted to increase from $3.25 billion in 2024 to $3.98 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 22.7%. Factors such as an upturn in drug development initiatives, a surge in genetic disorders and targeted diseases, wider adoption of compact portable devices, increased use of biomarker profiling, and a rise in demand for personalized medication, coupled with an increasing cancer patient population, have contributed to the growth observed in the historic period.
How is the ribonucleic acid (rna) sequencing market size expected to evolve during the forecast period?
The ribonucleic acid (RNA) sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.91 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.
Get your ribonucleic acid (rna) sequencing market report here!
Which key drivers are propelling the ribonucleic acid (rna) sequencing market’s growth?
The ribonucleic acid (RNA) sequencing market is anticipated to expand due to a heightened emphasis on precision medicine. This cutting-edge medical approach, also referred to as personalized medicine, takes into account individual variations in genes, environmental factors, and lifestyle habits. It holds the promise of yielding more effective treatments, driving genomics advancements, coping with increasing disease complexity, and garnerning regulatory support. RNA sequencing technology plays a fundamental role in determining the sequence and quantifying the expression levels of RNA molecules within a sample. This technology facilitates a detailed analysis of transcriptomes, producing insights into gene expression patterns, alternative splicing events, and RNA alterations. For example, in February 2024, the Personalized Medicine Coalition, a U.S. non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals in 2022. Consequently, the escalating emphasis on precision medicine is fueling the growth of the RNA sequencing market.
What are the market segments in the ribonucleic acid (rna) sequencing industry?
The ribonucleic acid (RNA) sequencing market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Kits, Software
2) By Technology: Single Molecule Based Sequencing, Sequence By Synthesis Technology, Nanopore Sequencing Technology, Ion Torrent Semiconductor Sequencing
3) By Applications: Diagnostics, Drug Discovery, Translational Medicine, Other Applications
4) By End User: Research And Academia, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Instruments: Next-Generation Sequencers, Microarray Instruments, Single-Cell Rna Sequencing Instruments
2) By Reagents And Kits: Rna Extraction Kits, Rna Sequencing Kits, Library Preparation Kits
3) By Software: Data Analysis Software, Data Management Software, Bioinformatics Software
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp
What are the top market players propelling the growth of the ribonucleic acid (rna) sequencing industry?
Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics
What key trends are currently impacting the ribonucleic acid (rna) sequencing market’s development?
Top firms in the RNA sequencing market are emphasizing on RNA next-generation sequencing assay to enhance patient care by utilizing data-driven intelligence and precision medicine. The RNA next-generation sequencing assay is a cutting-edge exome sequencing platform that employs top-tier genomic sequencing techniques to investigate a patient’s complete exome. For example, in June 2023, Tempus, a precision medicine technology enterprise based in the US, launched its standalone RNA next-generation sequencing assay, Tempus xR. This groundbreaking assay, tailored for solid tumors, provides comprehensive exploration of the total transcriptome, illuminating clinically crucial fusions in upwards of 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This product meets the needs of physicians who have a keen interest in RNA fusions or altered splicing, and it additionally serves providers, researchers, and biopharma companies in search of intensive RNA sequencing analysis of their current samples.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15665
Which geographic areas are influencing the growth of the ribonucleic acid (rna) sequencing market?
North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Returnable Packaging Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/returnable-packaging-global-market-report
External Cloud Automotive Cyber Security Services Global Market Report 2024
NGS-Based RNA-Sequencing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
